Dr David Sim shares the value of cardiac biomarkers – Natriuretic peptide as useful tools for the diagnosis, prognostication and management of heart failure.
Value of NT-ProBNP for Treatment Monitoring in CHF
17 February 2023
KEY TAKEAWAYS
- Cardiac biomarkers are useful tools for the diagnosis, prognostication and management of HFrEF and HFpEF.
- Future approaches should expand beyond biomarker monitoring in established disease states and try to prevent disease through early detection of at risk patients.
